We provide you with 20 years of free, institutional-grade data for BEAM stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of BEAM. Explore the full financial landscape of BEAM stock.
| Reported Date | CIK | Ticker | Type | |
|---|---|---|---|---|
| 2025-08-05 | 1745999 | BEAM | 10-Q | Url |
| 2025-05-06 | 1745999 | BEAM | 10-Q | Url |
| 2025-02-25 | 1745999 | BEAM | 10-K | Url |
| 2024-11-05 | 1745999 | BEAM | 10-Q | Url |
| 2024-08-06 | 1745999 | BEAM | 10-Q | Url |
| 2024-05-07 | 1745999 | BEAM | 10-Q | Url |
| 2024-02-27 | 1745999 | BEAM | 10-K | Url |
| 2023-11-08 | 1745999 | BEAM | 10-Q | Url |
| 2023-08-08 | 1745999 | BEAM | 10-Q | Url |
| 2023-05-10 | 1745999 | BEAM | 10-Q | Url |
| 2023-02-28 | 1745999 | BEAM | 10-K | Url |
| 2022-11-07 | 1745999 | BEAM | 10-Q | Url |
| 2022-08-09 | 1745999 | BEAM | 10-Q | Url |
| 2022-05-09 | 1745999 | BEAM | 10-Q | Url |
| 2022-02-28 | 1745999 | BEAM | 10-K | Url |
| 2021-11-08 | 1745999 | BEAM | 10-Q | Url |
| 2021-08-10 | 1745999 | BEAM | 10-Q | Url |
| 2021-05-11 | 1745999 | BEAM | 10-Q | Url |
| 2021-03-15 | 1745999 | BEAM | 10-K | Url |
| 2020-11-10 | 1745999 | BEAM | 10-Q | Url |
| 2020-09-28 | 1745999 | BEAM | S-1 | Url |
| 2020-08-12 | 1745999 | BEAM | 10-Q | Url |
| 2020-05-12 | 1745999 | BEAM | 10-Q | Url |
| 2020-03-30 | 1745999 | BEAM | 10-K | Url |
| 2019-09-27 | 1745999 | BEAM | S-1 | Url |
Beam Therapeutics Inc(NASDAQ:BEAM) 
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease...
Website: http://www.beamtx.com
Founded: 2017
Full Time Employees: 166
CEO: John Evans
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about BEAM stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.